MIR3142

Across TCGA pan-cancer cohorts, MIR3142 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated MIR3142 data layer compared with 8 for mass-spec protein.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher MIR3142 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated MIR3142 expression acts as an unfavorable survival marker.

ESCA are the cancer types where MIR3142 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	OS	Median	II,III,IV	0.102	0.703	<.001	36	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

MIR3142–ESCA (OS)

Open the ESCA breakdown →